Sign in
4

Changes in Ownership

Candel Therapeutics, Inc. Filed Acc 0001909680-26-000002

Chief Scientific Officer sold 23,447 shares at $10.06 ($235,769)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Barone Francesca Chief Scientific Officer 2026-06-29 Sale 10b5-1 −23,447 $10.06 $235,769 77,362 D: show line 1 in the form
Open-market sales · 23,447 sh · avg $10.06 · $235,769
Loading xslF345X06/ownership.xml…